American Society of Clinical Oncology

SHERPA: White

People

  1. Ilson
    Ilson
  2. Kelsen
    Kelsen
  3. Janjigian
    Janjigian
  4. Ku
    Ku
  5. Bains
    Bains
  6. Rusch
    Rusch
  7. Capanu
    Capanu
  8. Chou
    Chou
  9. Schultz
    Schultz
  10. Strong
    Strong

Groups

  1. Department of Medicine (131)
  2. Gastrointestinal Oncology Service (131)
  3. Solid Tumor Oncology Division (131)
  4. Center for Pancreatic Cancer Research (72)
  5. Epidemiology and Biostatistics (52)
  6. Survivorship Research (52)
  7. Hematologic Malignancies, Division of (49)
  8. Surgery (48)
  9. Biostatistics Service (43)
  10. GSK Faculty (22)
Search Within
  1. "David Ilson"
  2. "Gastrointestinal Oncology Service"
Formats
  1. Meeting Abstract (103)
  2. Journal Article (28)
Groups
  1. Department of Medicine (131)
  2. Gastrointestinal Oncology Service (131)
  3. Solid Tumor Oncology Division (131)
  4. Center for Pancreatic Cancer Research (72)
  5. Epidemiology and Biostatistics (52)
  6. Survivorship Research (52)

More Groups

People
  1. David Ilson (131)
  2. David Kelsen (55)
  3. Yelena Janjigian (54)
  4. Geoffrey Ku (47)
  5. Marinela Capanu (34)
  6. Manish Shah (26)

More People

Years
  1. 2023 (4)
  2. 2022 (5)
  3. 2021 (10)
  4. 2020 (7)
  5. 2019 (11)
  6. 2018 (8)

More Years

Publications
  1. Journal of Clinical Oncology (129)
  2. ASCO News & Forum (1)
  3. American Society of Clinical Oncology Educational Book (1)

Results (131)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Total neoadjuvant chemo (ctx; TNT) for locally advanced gastric cancer (GC): The Memorial Sloan Kettering Cancer Center experience
    Meeting Abstract

    Greally, M.; Strong, V. E.; Yoon, S. S.; Coit, D. G.; Chou, J. F.; Capanu, M.; Kelsen, D. P.; Janjigian, Y. Y.; Ilson, D. H.; Ku, G. Y.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Clinical and molecular factors predicting resistance to first-line (1L) FOLFOX in patients (pts) with advanced esophagogastric cancer (EGA) and patterns of subsequent therapy
    Meeting Abstract

    Greally, M.; Walch, H. S.; Chou, J. F.; Capanu, M.; Kelsen, D. P.; Ilson, D. H.; Janjigian, Y. Y.; Schultz, N.; Ku, G. Y.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Analysis of symptoms and functional HRQoL scales in TAGS, a phase III trial of trifluridine/tipiracil (FTD/TPI) in metastatic gastric cancer (mGC)
    Meeting Abstract

    Alsina, M.; Tabernero, J.; Shitara, K.; Doi, T.; Dvorkin, M.; Mansoor, W.; Arkenau, H. T.; Prokharau, A.; Ghidini, M.; Faustino, C.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Efficacy and safety of trifluridine/tipiracil (FTD/TPI) in patients (pts) with metastatic gastric cancer (mGC) with or without prior gastrectomy: Results from a phase III study (TAGS)
    Meeting Abstract

    Ilson, D. H.; Prokharau, A.; Arkenau, H. T.; Ghidini, M.; Fujitani, K.; Van Cutsem, E.; Thuss-Patience, P. C.; Beretta, G. D.; Mansoor, W.; Zhavrid, E.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O-) in HER2-positive metastatic esophagogastric adenocarcinoma (mEGA)
    Meeting Abstract

    Janjigian, Y. Y.; Chou, J. F.; Simmons, M.; Momtaz, P.; Sanchez-Vega, F.; Shcherba, M.; Ku, G. Y.; Won, E.; Chong, C. R.; Gerdes, H.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase I/Ib study of crenolanib with ramucirumab (RAM)/paclitaxel (PTX) as second -line therapy (2L tx) for advanced esophagogastric adenocarcinoma (EGA)
    Meeting Abstract

    Greally, M.; Jha, S.; Yoon, S. S.; Li, J.; Desai, A. M.; Won, E.; Kelsen, D. P.; Ilson, D. H.; Janjigian, Y. Y.; Aljallad, K.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Systemic chemo (CTX) plus surgery and intraperitoneal (IP) CTX for patients (pts) with gastric cancer (GC) and peritoneal carcinomatosis (PC)
    Meeting Abstract

    Greally, M.; Strong, V. E.; Yoon, S. S.; Chou, J. F.; Capanu, M.; Kelsen, D. P.; Janjigian, Y. Y.; Ilson, D. H.; Ku, G. Y.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Effect of post-discontinuation therapy (PDT) on survival in metastatic gastric-gastroesophageal junction (G-GEJ) adenocarcinoma patients from the RAINFALL trial: An exploratory analysis
    Meeting Abstract

    Shitara, K.; Shah, M. A.; Di Bartolomeo, M.; Lonardi, S.; Al-Batran, S. E.; Van Cutsem, E.; Ilson, D. H.; Chau, I.; Alsina, M.; Lacy, J.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Detection of germline homologous recombination deficiency (HRD) in patients with metastatic esophagogastric (EG) cancer using clinical next generation sequencing (NGS)
    Meeting Abstract

    Janjigian, Y. Y.; Jonsson, P.; Kemel, Y.; Joseph, V.; Tuvy, Y.; Shameer, Z.; Ravichandran, V.; Zhang, L. Y.; Mandelker, D.; Ku, G. Y.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • PET scan-directed chemoradiation (CRT) for esophageal squamous cell carcinoma (ESCC): No benefit for salvage chemo in PET non-responders (PETnr)
    Meeting Abstract

    Greally, M.; Chou, J. F.; Molena, D.; Rusch, V. W.; Bains, M. S.; Park, B. J.; Wu, A. J. C.; Kelsen, D. P.; Janjigian, Y. Y.; Ilson, D. H.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save